|
RAB10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6251444634463E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.06420000484309E-09 |
| Normal-vs-Stage2 |
4.07789999999908E-05 |
| Normal-vs-Stage3 |
4.67514915669653E-13 |
| Normal-vs-Stage4 |
1.70963243562028E-12 |
| Stage1-vs-Stage2 |
5.158600E-01 |
| Stage1-vs-Stage3 |
2.894400E-02 |
| Stage1-vs-Stage4 |
3.63490000000466E-05 |
| Stage2-vs-Stage3 |
5.190200E-02 |
| Stage2-vs-Stage4 |
2.784300E-03 |
| Stage3-vs-Stage4 |
6.842000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.86010121036884E-11 |
| Normal-vs-AfricanAmerican |
1.097490E-03 |
| Normal-vs-Asian |
7.25890000330409E-08 |
| Caucasian-vs-AfricanAmerican |
2.794000E-01 |
| Caucasian-vs-Asian |
4.820600E-01 |
| AfricanAmerican-vs-Asian |
5.117000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.3266054921246E-11 |
| Normal-vs-Female |
1.6278089987054E-12 |
| Male-vs-Female |
7.002000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.53880002868357E-09 |
| Normal-vs-Age(41-60Yrs) |
1.73194791841524E-14 |
| Normal-vs-Age(61-80Yrs) |
4.53770354624794E-11 |
| Normal-vs-Age(81-100Yrs) |
1.078500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.144100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.816380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.921200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.652000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.855600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.461400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.634300E-02 |
| Classical-VS-Follicular |
1.638160E-02 |
| Classical-VS-Other |
3.818800E-01 |
| Classical-VS-Normal |
7.68790031635547E-10 |
| Tall-VS-Follicular |
1.648640E-04 |
| Tall-VS-Other |
7.640600E-01 |
| Tall-VS-Normal |
1.70989888914619E-11 |
| Follicular-VS-Other |
1.527580E-01 |
| Follicular-VS-Normal |
3.78659999999975E-05 |
| Other-VS-Normal |
1.063250E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.53597143284878E-12 |
| Normal-vs-N1 |
1.31670230274494E-11 |
| N0-vs-N1 |
4.606300E-02 |
|
|
